Schedule 13G ownership disclosure

Collegium Pharmaceutical Inc

COMMON STOCK · CUSIP: 19459J104

Event date: 2026-09-30

Filing-level shares
1,772,243.00
Percent of class
5.4%
  • STATE STREET CORPORATION

    Shares: 1,772,243.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000632
Form type
SCHEDULE 13G
Filer
COLLEGIUM PHARMACEUTICAL, INC
CIK
CIK 1267565
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub